Hamideh Zarrinmayeh

Synthesis and Evaluation of a Series of Novel 2-[(4-Chlorophenoxy)methyl]- benzimidazoles as Selective Neuropeptide Y Y1 Receptor Antagonists

Hamideh Zarrinmayeh, Anne M. Nunes, Paul L. Ornstein et al. · Journal of Medicinal Chemistry · 1998 · 153 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Duocarmycin-pyrindamycin DNA alkylation properties and identification, synthesis, and evaluation of agents incorporating the pharmacophore of the duocarmycin-pyrindamycin alkylation subunit. Identification of the CC-1065 duocarmycin common pharmacophore

Dale L. Boger, Takayoshi Ishizaki, Hamideh Zarrinmayeh et al. · Journal of the American Chemical Society · 1990 · 136 citations

Medicine, Medicinal Chemistry, Pharmacology +7

An alternative and convenient strategy for generation of substantial quantities of singly 5′-32p-end-labeled double-stranded DNA for binding studies: Development of a protocol for examination of functional features of (+)-CC-1065 and the duocarmycins that contribute to their sequence-selective DNA alkylation properties

Dale L. Boger, Stephen A. Munk, Hamideh Zarrinmayeh et al. · Tetrahedron · 1991 · 104 citations

Pharmacy, Chemical Biology, Molecular Biology +5

Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC-1065/duocarmycin common pharmacophore

Dale L. Boger, Takayoshi Ishizaki, Hamideh Zarrinmayeh et al. · The Journal of Organic Chemistry · 1990 · 93 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists

Hamideh Zarrinmayeh, Dennis M. Zimmerman, Buddy E. Cantrell et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 91 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13